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The role of dopamine D1-like receptors (DR) in the regulation of renal sodium transporters, 21 
natriuresis, and blood pressure is well established. However, the involvement of Angiotensin 22 
(Ang) 1-7—Mas receptor (MasR) in the regulation of sodium balance and blood pressure is not 23 
clear. This study aims to investigate the hypothesis that Ang 1-7 could regulate sodium 24 
homeostasis by modulating renal dopamine system. Sprague Dawley rats were infused with 25 
saline alone (vehicle) or saline with Ang 1-7, Ang 1-7 antagonist A-779, DR agonist SKF38393, 26 
and antagonist SCH23390. Infusion of Ang 1-7 caused significant natriuresis and diuresis when 27 
compared to saline alone. Both natriuresis and diuresis were blocked by A-779 and SCH23390. 28 
SKF38393 caused a significant, SCH23390 sensitive, natriuresis and diuresis and A-779 had no 29 
effect on SKF38393 response. Concomitant infusion of Ang 1-7 and SKF38393 did not show a 30 
cumulative effect when compared to either agonist alone. Treatment of renal proximal tubules 31 
with Ang 1-7 or SKF38393 caused a significant decrease in Na/K-ATPase and Na/H-Exchanger 32 
(NHE) 3 activity. While SCH23390 blocked both Ang 1-7 and SKF38393 induced inhibition, 33 
DR response was not sensitive to A-779. Additionally, Ang 1-7 activated protein kinase (PK) G, 34 
enhanced tyrosine hydroxylase activity via serine-40 phosphorylation and increased renal 35 
dopamine production. These data suggest that Ang 1-7 via PKG enhances tyrosine hydroxylase 36 
activity which increases renal dopamine production and activation of DR and subsequent 37 
natriuresis. These studies provide evidence for a unidirectional functional interaction between 38 
two G protein-coupled receptors to regulate renal sodium transporters and induce natriuresis.  39 
Keywords: Na/K-ATPase, Na/H-Exchanger, Natriuresis, Renal Tubules  40 
 41 




It is well established that renal dopamine system plays a pivotal role in maintaining body fluid 43 
and electrolyte balance and long term blood pressure regulation especially during sodium replete 44 
condition (17, 40, 53). Renal dopamine activates D1-like receptors (DR) and inhibits tubular 45 
sodium transporters such as Na/K-ATPase and Na/H-Exchanger (NHE) 3 and causes natriuresis 46 
and diuresis (10, 23, 36, 51). It is believed that the renal dopaminergic system is a local 47 
independent system that acts in an autocrine or paracrine manner (2, 3, 12). The renal dopamine 48 
production is dependent upon the tubular uptake of L-3,4-dihydroxyphenylalanine (L-DOPA) 49 
and enzymatic activity of aromatic L-amino acid decarboxylase (AADC) which converts L-50 
DOPA to dopamine (2, 3, 12). The proximal tubules exhibit a high concentration of AADC and 51 
are considered the primary source of renal dopamine (3, 12, 13, 17). It has been demonstrated 52 
that renal specific deletion of AADC in mice leads to the development of hypertension and salt 53 
sensitivity (57). Although, it has been postulated that other transporters belonging to solute 54 
carrier superfamily which include basolateral organic cation transporters (OCT1, OCT2, and 55 
OCT3) and apical transporters (OCTN1, OCTN2, and OCTN3) also play a role in dopamine 56 
transport, their impact on sodium regulation is not clear (30, 31, 55). It is widely perceived that 57 
L-DOPA, freely filtered by the glomerulus, is transported into proximal tubules mainly by 58 
sodium-independent L-amino acid transporter (LAT) 2 making it a rate-limiting step in 59 
dopamine synthesis (3, 11, 27, 45). However, recent studies show that an alternative pathway 60 
involving tyrosine hydroxylase an enzyme which converts tyrosine to L-DOPA, a rate-limiting 61 
step in neuronal dopamine synthesis, could be contributing to tubular dopamine production (52).  62 
Renal Dopamine interacts with Angiotensin (Ang) II receptors, both type 1 and type 2 to 63 
regulate sodium balance and blood pressure (15, 35, 40, 41, 46, 50). While the interaction with 64 
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Ang II type 1 receptor is antagonistic in that dopamine suppresses Ang II-mediated 65 
antinatriuretic pathway, the interaction with type 2 receptors is synergistic as DR stimulation 66 
induces natriuresis via Ang type 2 receptor (15, 35, 40, 41, 46, 50). However, little is known 67 
about the interaction of renal dopamine with Ang 1-7—Mas receptor (MasR) system. The role of 68 
Ang 1-7 in renal sodium is controversial, with some studies suggesting antinatriuretic effect 69 
while others showing natriuretic effect (21, 37, 38, 43). It has been shown that Ang 1-7 can 70 
activate serine/threonine protein kinases and inhibits renal proximal tubular sodium transporters 71 
however, the mechanism remains unclear (14, 34). It is reported that Ang 1-7 activates protein 72 
kinase (PK) G and PKG has been shown to stimulate tyrosine hydroxylase by phosphorylating 73 
the enzyme at serine-40 (22, 26). Activation of tyrosine hydroxylase converts tyrosine to L-74 
DOPA, a rate limited step in dopamine synthesis. Interestingly, both PKG and tyrosine 75 
hydroxylase are highly expressed in epithelial cells (1, 16, 20, 29, 52). Therefore, here we test 76 
the hypothesis that Ang 1-7—MasR signaling could increase renal dopamine production via 77 
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Experimental procedure 86 
Materials 87 
Angiotensin (Ang ) 1-7 (Asp-Arg-Val-Tyr-Ile-His-Pro), A-779 (D-Ala7-Ang-(1-7)—a selective 88 
Ang 1-7 antagonist,  ouabain—a Na/K-ATPase inhibitor, S3226 (3-[2-(3-guanidino-2-methyl-3-89 
oxo-propenyl)-5-methyl-phenyl]-N-isopropylidene-2-methyl-acrylamide dihydro-chloride)—a 90 
Na/H-Exchanger (NHE) 3 inhibitor, KT5823—a protein kinase (PK) G inhibitor, HBH (3-91 
Hydroxybenzylhydrazine dihydrochloride)—an aromatic L-amino acid decarboxylase (AADC) 92 
inhibitor, (3-Iodo-L-tyrosine)—a tyrosine hydroxylase inhibitor, KT5720—a protein kinase (PK) 93 
A inhibitor, monoclonal anti-tyrosine hydroxylase antibody (catalog number: T2928), anti-94 
phospho-tyrosine hydroxylase (pSer40) antibody (catalog number: SAB4503789), secondary 95 
antibodies and other analytical grade chemicals, unless otherwise mentioned, were purchased 96 
from Millipore Sigma (St. Louis MO, USA). Protein kinase G-1 antibody (catalog number: 97 
3248) was purchased from Cell Signaling (Danvers, MA).   98 
Surgical procedure for Ang 1-7 renal response 99 
Eight-week-old male Sprague Dawley rats (Harlan, Indianapolis, IN) were group housed and had 100 
free access to water and normal rodent diet. All the experimental procedures were approved by 101 
IACUC. Surgeries were performed as detailed before (39), briefly, rats were anesthetized with 102 
isoflurane/oxygen mixture and blood pressure was measured by catheterizing the left carotid 103 
artery with a solid state pressure transducer connected to power lab (ADI Colorado Springs CO, 104 
USA). For drug administration, the left jugular vein was catheterized with PE50 and for urine 105 
collection, a midline abdomen incision was made to catheterize urinary bladder. Throughout the 106 
surgery, the animals were infused with normal saline (1% body wt ml/h) and blood pressure and 107 
heart rate were continuously monitored. To determine the effect of Ang 1-7 on sodium and water 108 
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excretion rats were infused with saline alone or saline with Ang 1-7 (1 μg·kg-1·min-1) or 109 
SKF38393 (1 μg·kg-1·min-1).  A-779 (100 μg·kg-1), SCH23390 (100 μg·kg-1) or KT5823 (10 110 
μg·kg-1) were administered intravenously as a single bolus dose immediately prior to the 111 
initiation of Ang 1-7 or SKF38393 infusion. The procedure consisted of a 40 min stabilization 112 
period after the surgery followed by a 45 min collection of urine in the absence of drugs (saline 113 
alone) followed by another 45 min period urine collection during drug infusion. Urine and 114 
plasma sodium concentration was measured by atomic absorbance spectroscopy (Perkin Elmer 115 
AA400) and creatinine levels were measured by creatinine analyzer (model 2, Beckman, CA). 116 
Urinary volume was measured by Rainin electronic pipet (Mettler-Toledo Rainin, Oakland CA, 117 
USA). Glomerular filtration rate (GFR, ml/min) was calculated based on the clearance of 118 
creatinine, and fractional excretion of sodium (FENa, %) was calculated based on the clearance of 119 
sodium and creatinine. Urinary dopamine was measured by HPLC-mass spectrometry as detailed 120 
before (6). 121 
Na/K-ATPase and Na/H-Exchanger activity 122 
A separate group of rats was used to prepare renal proximal tubules as detailed in our previous 123 
publications (6-8). Renal proximal tubules were incubated for 10 min at 37°C with Ang 1-7 (0.1 124 
µmol/L), SKF38393 (0.1 µmol/L), A-779 (10.0 µmol/L), SCH23390 (10.0 µmol/L), KT5823 125 
(1.0 µmol/L), HBH (100 µmol/L), and 3-Iodo-L-tyrosine (100.0 µmol/L). Na/K-ATPase activity 126 
was determined by the method of Quigley and Gotterer (47) with slight modification as reported 127 
earlier (6-8). The tubules were lysed by rapid freezing and thawing with liquid nitrogen and 128 
protein was assayed by using a BCA kit (Thermo Fisher). The lysed tubular suspension (0.1 mg 129 
protein/ml) was used to assay ouabain (4 mmol/L)-sensitive Na/K-ATPase activity, using end-130 
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point phosphate hydrolysis of ATP (4 mmol/L) (6-8). NHE3 activity was measured in proximal 131 
tubular brush border membranes as detailed before (7). 132 
Tyrosine hydroxylase and Protein Kinase G expression and activity 133 
Tyrosine hydroxylase expression and phosphorylation were determined by ELISA or western 134 
blotting according to our previously published standardized protocol (5, 9). Briefly, microplates 135 
were coated with an antigen (equal amount of cell lysate protein) and incubated with anti-136 
tyrosine hydroxylase or anti-phospho-tyrosine hydroxylase (pSer40) antibody and quantitated by 137 
ELISA (5). We also coated microplates with an anti-tyrosine hydroxylase or anti-phospho-138 
tyrosine hydroxylase (pSer40) antibody followed by incubation with an equal amount of cell 139 
lysate protein followed by ELISA (5). Renal proximal tubular tyrosine hydroxylase activity was 140 
measured as described by Baillien et at (4). Briefly, proximal tubules were homogenized in 141 
potassium phosphate buffer (50 mmol/L, pH 6.0) and 80 mg (1mg/ml protein concentration) was 142 
added to an assay mixture containing 25 mmol/L L-tyrosine, ferrous ammonium sulfate (10 143 
mmol/L), catalase (3,200 units), ascorbic acid (1 mmol/L), tetrahydrobiopterin and 0.1 mmol/L 144 
HBH dissolved fresh in a small volume of 0.01 mol/L HCl, 50 mmol/L potassium phosphate 145 
buffer pH 6.0 without and with 3-Iodo-L-tyrosine (100 µmol/L). The mixture was incubated for 146 
15 min at 37°C and the reaction was stopped by adding chilled 10% trichloroacetic acid and 147 
DOPA was measured by HPLC-mass spectrometry as described by Haavik and Flatmark (28) 148 
and detailed in our previous publication (6). PKG expression was determined by ELISA (5) and 149 
activity was measured as described by Fiscus and Murad (25) and detailed previously (9). Renal 150 
proximal tubular PKA activity was determined as detailed by Corbin and Reimann (18) in the 151 
absence and presence of forskolin (10 µmol/L), KT5720 (0.3 µmol/L) and KT5823 (1.0 µmol/L).  152 
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Statistical analysis  153 
Differences between means were evaluated by using ANOVA followed by post-hoc Newman-154 
Keuls multiple test. P< 0.05 was considered statistically significant. For in vivo experiments 155 
(drug infusion), 10-12 rats were used in each group, and for ex vivo experiments involving 156 
proximal tubules, 6-8 rats were used in each group. Experiments involving biochemical analysis 157 
were performed in quadruplicate. ELISA was performed in quintuplicate i.e. at least 5 wells were 158 

















Effect of Ang 1-7 on urine flow, urinary sodium excretion, fractional excretion of sodium, and 173 
urinary dopamine excretion  174 
Intravenous administration of Ang 1-7 significantly increased urine flow (UF), urinary sodium 175 
excretion (UNa), and fractional excretion of sodium (FENa) when compared to saline infusion 176 
alone (fig 1A-C). Ang 1-7 had no effect on GFR (fig 1D). Ang 1-7 –mediated increases in UV, 177 
UNa, and FENa were abolished by Ang 1-7 antagonist A-779 and DR blocker SCH23390 (fig 178 
2A-C). SKF38393 –mediated natriuresis and diuresis was blocked by SCH23390 but was 179 
insensitive to A-779 (fig 2A-C). Concomitant administration of Ang 1-7 and SKF38393 did not 180 
have a cumulative effect on natriuresis or diuresis when compared to Ang 1-7 or SKF38393 181 
alone (fig A-C). A-779 per se had no effect while SCH23390 alone or in combination with A-182 
779 reduced UF, UNa, or FENA but the difference was not statistically significant when 183 
compared to saline (data not shown). Ang 1-7 and SKF38393 had no effect on blood pressure as 184 
compared to saline (mean arterial pressure, mmHg, saline—107.33 ± 5.36, Ang 1-7—101.03 ± 185 
6.01, SKF38393—105.65 ± 4.88). A-779 and SCH23390 also had no significant effect on blood 186 
pressure (data not shown). 187 
Ang 1-7 administration caused a profound increase in urinary dopamine excretion as compared 188 
to saline (dopamine pmol/min, saline—4.63 ± 0.41, Ang 1-7—8.91 ± 0.71*, *P<0.05 vs. saline). 189 
The increase in dopamine production was blocked by A-779 and KT5823 but was insensitive to 190 
SCH23390 (Ang 1-7+A-779—5.32 ± 0.51, Ang1-7+KT5823—5.03 ± 0.44, Ang 1-191 
7+SCH23390—9.1 ± 0.89*, *P<0.05 vs. saline). In the absence of Ang 1-7, SKF38393, 192 
SCH23390, A-779 and KT5823, per se, had no significant effect on basal dopamine excretion 193 
(data not shown). 194 
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Effect of Ang 1-7 on renal sodium transporters 195 
Incubation of renal proximal tubules with Ang 1-7 or SKF38393 inhibited Na/K-ATPase and 196 
NHE3 activity significantly as compared to saline (fig 3A,B). The inhibitory effect of Ang 1-7 197 
on sodium transporters was sensitive to both A-779 and SCH23390 (fig 3A,B). However, 198 
SCH23390 and not A-779 blocked DR –mediated inhibition of sodium transporters. Concomitant 199 
incubation of proximal tubules with Ang 1-7 and SKF38393 did not have a cumulative inhibitory 200 
effect on the sodium transporters (fig 3A,B). A-779 and SCH23390 had no effect on basal Na/K-201 
ATPase (nmol pi/min/mg protein, saline—225.33 ± 16.36, A-779—239.29 ± 21.22, 202 
SCH23390—241.69 ± 19.89) and NHE3 activity (22Na+ nmol/mg protein/min, saline—5.3 ± 203 
0.42, A-779—4.9 ± 0.39, SCH23390—5.1 ± 0.44). 204 
  Effect of Ang 1-7 on protein kinase G and tyrosine hydroxylase expression and activity 205 
Ang 1-7 had no effect on PKG expression in renal proximal tubules (PKG-1 (α/β), OD at 450 206 
nm; saline—0.67 ± 0.11, Ang 1-7—0.74 ± 0.13). However, Ang 1-7 significantly increased 207 
proximal tubular PKG activity which was blocked by A-779 and PKG inhibitor KT5823 but was 208 
insensitive to SCH23390 (fig 4A). KT5823 could inhibit PKA activity at higher concentration. 209 
As illustrated in figure 4B, the concentration of KT5823 (1.0 µmol/L) used in the present study 210 
had no effect on PKA activity whereas KT5720, a more specific PKA inhibitor, reduced both 211 
basal activity and forskolin-induced activation of PKA. Ang 1-7 did not affect tyrosine 212 
hydroxylase expression (OD at 450 nm; saline—0.83 ± 0.17, Ang 1-7—0.91 ± 0.13), figure 213 
4C—lower panel and supplement figure 1 [URL: https://figshare.com/s/49cecaa9c0fe7a7c6949   214 
DOI: 10.6084/m9.figshare.9201893]. However, Ang 1-7 significantly increased tyrosine 215 
hydroxylase serine-40 phosphorylation (fig 4C—upper panel, fig 4D and supplement fig 2, 216 
[URL: https://figshare.com/s/49cecaa9c0fe7a7c6949  DOI: 10.6084/m9.figshare.9201893]) and 217 
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activity (fig 4E), both of which were blocked by A-779 and KT5823 while SCH23390 had no 218 
effect (fig 4C-E). Tyrosine hydroxylase inhibitor 3-Iodo-L-tyrosine had no effect on Ang 1-7-219 
mediated serine-40 phosphorylation (fig 4C—upper panel, fig 4D) but reduced basal tyrosine 220 
hydroxylase activity and abolished Ang 1-7-induced stimulation (fig 4E). The basal tyrosine 221 
hydroxylase activity was not affected by A-779, SCH23390 or KT5823 (data not shown).  222 
Effect of protein kinase G, tyrosine hydroxylase and dopamine decarboxylase inhibition on Ang 223 
1-7-mediated inhibition of renal sodium transporters 224 
Exposure of proximal tubules to PKG, tyrosine hydroxylase, and AADC inhibitors KT5823, 3-225 
Iodo-L-tyrosine and HBH respectively had no effect on basal Na/K-ATPase (fig 5A) or NHE3 226 
activity (data not shown). However, inhibition of PKG, tyrosine hydroxylase and AADC 227 
abolished Ang 1-7 –mediated regulation of both Na/K-ATPase and NHE3 (fig 5B,C). Inhibitors 228 
of PKG, tyrosine hydroxylase, and AADC failed to abolish SKF38393-induced inhibition of 229 













The present study demonstrates that Ang 1-7—MasR signaling increases renal dopamine 240 
production by stimulating PKG—tyrosine hydroxylase activity. Moreover, the increased 241 
dopamine production via DR inhibits renal sodium transporters Na/K-ATPase and NHE3 and 242 
induces natriuresis and diuresis in response to Ang 1-7—MasR stimulation. Our results suggest 243 
that Ang 1-7—MasR signaling regulates renal sodium excretion by modulating local dopamine 244 
production. 245 
Ang 1-7, a relatively newer member of the renin-angiotensin-aldosterone system, is 246 
enzymatically generated directly from Ang 1 and Ang II by neprilysin  and angiotensin-247 
converting enzyme 2 respectively or indirectly by angiotensin-converting enzyme 2 –mediated 248 
conversion of Ang I to Ang 1-9, which is converted to Ang 1-7 by neprilysin or angiotensin-249 
converting enzyme (48, 56). Proximal tubules are exposed to circulating Ang 1-7 as well as Ang 250 
1-7 from the glomerular filtrate. In addition, kidneys are exposed to locally generated Ang 1-7 251 
explaining the higher renal vs. circulating Ang 1-7 levels. The role of Ang 1-7, unlike Ang II, in 252 
kidney electrolyte regulation is not clear. While earlier reports suggested anti- natriuretic and 253 
diuretic properties of renal Ang 1-7 in rats, recent reports show that Ang 1-7 deficit could 254 
contribute to Ang II-mediated sodium and water retention and subsequent increase in blood 255 
pressure (32). The exact mechanisms for these discrepancies are not known, however, the 256 
variability in animal model, experimental site (ex vivo vs. in vivo) and drug administration route 257 
could be possible causes for the variable outcome of Ang 1-7 effect on renal sodium regulation. 258 
In here, we found that acute Ang 1-7 administration caused robust natriuresis and diuresis 259 
without affecting GFR or blood pressure suggesting a tubular effect. As expected, the 260 
intravenous infusion of SKF38393 caused significant natriuresis and diuresis. Interestingly, the 261 
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effects of Ang 1-7 were abolished by both Ang 1-7 antagonist and DR blocker however, the 262 
effect of DR agonist was insensitive to Ang 1-7 antagonist. These data suggest that Ang 1-7—263 
MasR –mediated sodium excretion involves DR activation while the natriuretic response to 264 
SKF38393 is independent of Ang 1-7—MasR signaling. These findings are novel as they 265 
identify a unidirectional, as opposed to mutual, interaction between two G protein-coupled 266 
receptors to increase renal sodium excretion.  267 
To identify the mechanisms for Ang 1-7—MasR and DR interaction in increasing sodium 268 
excretion, we assessed the effect of Ang 1-7—MasR signaling on renal tubular sodium 269 
transporters. The exposure of renal proximal tubules to Ang 1-7 or SKF38393 inhibited Na/K-270 
ATPase and NHE3 activity. Interestingly, the Ang 1-7 –induced inhibition of sodium 271 
transporters was sensitive to both A-779 and SCH23390 while DR effect was independent of 272 
Ang 1-7 signaling. These data show that Ang 1-7—MasR inhibits renal tubular transporters via 273 
DR activation and is in agreement with aforementioned in vivo finding. To find a link between 274 
Ang 1-7—MasR and DR signaling as it relates to renal sodium regulation, we first measured 275 
urinary dopamine excretion. We found that Ang 1-7 treated rats exhibited a significant increase 276 
in urinary dopamine level which was blocked by A-779 but insensitive to SCH23390 suggesting 277 
that increased dopamine production involves Ang 1-7—MasR signaling but is independent of 278 
DR. Taken together, our data show that Ang 1-7—MasR stimulation increases renal dopamine 279 
production which activates DR causing inhibition of Na/K-ATPase and NHE3 activity. The role 280 
of Ang 1-7 in dopamine production and renal sodium regulation is conflicting. In contrast to our 281 
data, Pawlak et al (44) reported that AT1R blockade is needed for Ang 1-7-mediated dopamine 282 
production in rat hypothalamus and Stragier et al (49) showed that conversion of Ang 1-7 to Ang 283 
3-7 is responsible for dopamine production in rat striatum. Lara et al (33, 34) have shown that 284 
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Ang 1-7 via AT1R stimulates Na+-ATPase in adult pig renal tubules and inhibits Na/K-ATPase 285 
in MDCK cells, however, the same group failed to observe Ang 1-7-mediated inhibition of 286 
Na/K-ATPase in pig renal tubules (14). Consistent with our studies, DelliPizzi et al have shown 287 
renal natriuretic effects of Ang 1-7 in rats (19). The exact mechanisms for these discrepancies are 288 
not clear however the plausible explanation could be differences in animal model, central vs. 289 
peripheral effect of Ang 1-7, water and sodium replete vs. deplete condition and local renin-290 
angiotensin concentration. Nevertheless, we suggest that DR dependent inhibition of sodium 291 
transporters could, in part, be responsible for Ang 1-7—MasR-mediated natriuresis and diuresis 292 
as these transporters are responsible for more than 60% of transcellular proximal tubular sodium 293 
reabsorption (24, 54).   294 
In neuronal cells, the rate-limiting step of dopamine synthesis involves tyrosine 295 
hydroxylase –mediated conversion of tyrosine to L-DOPA which is decarboxylated to dopamine 296 
by AADC (42). However, it is widely perceived that in kidney dopamine is locally synthesized 297 
and involves apical uptake of filtered L-DOPA mainly via Lat 1 and Lat 2 (1-3, 11-13, 27, 45). 298 
The involvement of transporters belonging to solute carrier superfamily have also been suggested 299 
(30, 31, 55). However, the role of tyrosine hydroxylase, which is highly expressed in epithelial 300 
cells, has not been fully assessed in renal dopamine synthesis (1, 20, 29, 52). The activity of 301 
tyrosine hydroxylase is highly regulated by serine phosphorylation involving various 302 
serine/threonine kinases and phosphatases (22). While an increase in phosphorylation at serine-303 
40 is known to activate the enzyme, the role of serine-19 or serine-31 is not clear (22). Herein, 304 
we found that Ang 1-7 had no effect on tyrosine hydroxylase expression but increased enzyme 305 
serine-40 phosphorylation and activity. Ang 1-7 also increased PKG activity in renal tubules 306 
without affecting PKG expression. Ang 1-7 mediated activation of both tyrosine hydroxylase and 307 
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PKG were sensitive to A-779 but independent of DR signaling. Additionally, Ang 1-7—MasR –308 
mediated serine-40 phosphorylation and activation were blocked by PKG inhibition. These data 309 
provide strong evidence that Ang 1-7—MasR pathway increases dopamine production via 310 
activation of tyrosine hydroxylase involving PKG. 311 
To further substantiate the involvement of PKG—tyrosine hydroxylase in Ang 1-7—Mas 312 
R mediated sodium excretion, we assessed Ang 1-7-induced inhibition of Na/K-ATPase and 313 
NHE3 in the absence and presence of PKG, tyrosine hydroxylase, and AADC inhibitors. We 314 
found that Ang 1-7—MasR –mediated inhibition of renal sodium transporters was sensitive to 315 
PKG, tyrosine hydroxylase, and AADC inhibitors while these inhibitors had no effect on DR 316 
signaling. Additionally, the infusion of PKG inhibitor abolished Ang 1-7-mediated increase in 317 
urinary dopamine excretion. These data suggest that Ang 1-7—MasR –mediated renal sodium 318 
regulation involves the modulation of local renal dopamine synthesis. 319 
Limitations: The transport of renal tubular L-DOPA and tyrosine is complex and involves both 320 
apical and basolateral, sodium-dependent and independent transporters. A detailed study is 321 
warranted to identify the involvement of individual transporter in Ang 1-7—MasR signaling as it 322 
relates to renal dopamine synthesis and sodium regulation. The investigation of these 323 
transporters is beyond the scope of this study.  324 
In conclusion, our data show that Ang 1-7—MasR invokes robust natriuresis and diuresis via 325 
activation of renal DR. Mechanistically, Ang 1-7—MasR increased PKG activity, which 326 
activates tyrosine hydroxylase by serine-40 phosphorylation. The activation of tyrosine 327 
hydroxylase leads to increased dopamine production and DR stimulation which in turn inhibits 328 
renal sodium transporters Na/K-ATPase and NHE3. These phenomena lead to natriuresis and 329 
diuresis in response to Ang 1-7. While Ang 1-7—MasR –mediated renal sodium regulation is 330 
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dependent upon DR stimulation, SKF38393—DR –induced sodium excretion does not involve 331 
Ang 1-7—MasR signaling. Taken together, this study provides a novel insight into the 332 
complexity of renal sodium and dopamine regulation involving Ang 1-7—MasR and DR 333 
interaction. 334 
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Figure legends 527 
Figure 1. Effect of angiotensin (Ang) 1-7 on urine flow (UF), urinary sodium excretion (UNa), 528 
fractional excretion of sodium (FENa), and glomerular filtration rate (GFR). Rats were infused 529 
with saline and urine was collected for 45 min to establish a baseline. One group was continued 530 
on saline while the other group was administered Ang 1-7 in saline for 45 min. (A) Urine flow, 531 
(B) urinary sodium excretion, (C) fractional excretion of sodium and (D) glomerular filtration 532 
rate were measured as detailed in material and method. *P<0.05 vs. saline, repeated measures 533 
ANOVA followed by Newman-Keuls post hoc test; n=10-12 rats. 534 
Figure 2. Effect of angiotensin (Ang) 1-7 and dopamine D1-like receptor (DR) agonist 535 
SKF38393 on urine flow (UF), urinary sodium excretion (UNa), and fractional excretion of 536 
sodium (FENa). Rats were infused with saline alone or saline with Ang 1-7, SKF38393, Ang 1-7 537 
antagonist A-779, and DR blocker SCH23390.  After initiating drug infusion, urine was collected 538 
for 45 to measure (A) Urine flow, (B) urinary sodium excretion, (C) fractional excretion of 539 
sodium. *P<0.05 vs. saline, 1-way ANOVA followed by Newman-Keuls post hoc test; n=10-12 540 
rats. 541 
Figure 3. Effect of angiotensin (Ang) 1-7 and dopamine D1-like receptor (DR) agonist 542 
SKF38393 on renal proximal tubular sodium transporters Na/K-ATPase and Na/H-Exchanger 543 
(NHE) 3. Proximal tubules were incubated with Ang 1-7 and SKF38393 in the presence and 544 
absence of Ang 1-7 antagonist A-779 and DR blocker SCH23390. Na/K-ATPase activity was 545 
measured directly in lysed tubules (A), while NHE3 activity was measured in brush border 546 
membranes isolated after incubation of tubules with desired drugs (B). *P<0.05 vs. saline, 1-way 547 
ANOVA followed by Newman-Keuls post hoc test, n=6-8 rats. Na/K-ATPase and NHE3 were 548 
assayed in quadruplicate from each rat. 549 




Figure 4. Effect of angiotensin (Ang) 1-7 on protein kinase (PK) G and tyrosine hydroxylase 551 
expression and activity. Renal proximal tubules were incubated with Ang 1-7 in the presence and 552 
absence of Ang 1-7 antagonist A-779, DR blocker SCH23390, PKG inhibitor KT5823, and 553 
tyrosine hydroxylase inhibitor 3-Iodo-L-tyrosine. Renal proximal tubular PKG activity (A) and 554 
protein kinase A activity (B). Tyrosine hydroxylase (TH) expression and phosphorylation were 555 
determined by western blotting (C) and ELISA (D). Tyrosine hydroxylase activity was 556 
determined by HPLC-mass spectrometry (E). *P<0.05 vs. saline, 1-way ANOVA followed by 557 
Newman-Keuls post hoc test; n=6-8 rats. PKG and tyrosine hydroxylase activity was assayed in 558 
quadruplicate while expression and serine-40 phosphorylation (ELISA) was performed in 559 
quintuplicate from each rat. 560 
Figure 5. Role of dopamine synthesis enzymes on angiotensin (Ang) 1-7 –induced inhibition of 561 
sodium transporters Na/K-ATPase and Na/H-Exchanger (NHE) 3. Proximal tubules were 562 
incubated with Ang 1-7 and SKF38393 in the presence and absence of PKG inhibitor KT5823, 563 
tyrosine hydroxylase inhibitor 3-Iodo-L-tyrosine, and aromatic L-amino acid decarboxylase 564 
(AADC) inhibitor 3-Hydroxybenzylhydrazine dihydrochloride (HBH). Na/K-ATPase activity 565 
was measured directly in lysed tubules (A and B), while NHE3 activity was measured in brush 566 
border membranes isolated after incubation of tubules with desired drugs (C). *P<0.05 vs. saline, 567 
1-way ANOVA followed by Newman-Keuls post hoc test, n=6-8 rats. Na/K-ATPase and NHE3 568 
were assayed in quadruplicate from each rat. 569 
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